Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery [Phase 2]
Phase 2 clinical trial evaluating hepatic artery infusion chemotherapy with donafenib in hepatocellular carcinoma after surgery.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of "Immuncell-LC" in TACE Therapy [Phase 2]
A Phase 2 clinical trial evaluated the safety and efficacy of Immuncell-LC as an adjunct in transarterial chemoembolization for hepatocellul…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma [Phase 3]
A Phase 3 study evaluating the combination of durvalumab and tremelimumab as first-line therapy for advanced hepatocellular carcinoma has re…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating the combination of chemoembolization and stereotactic body radiation therapy for unresectable hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating iCaritin soft capsule in combination with lenvatinib and TACE for hepatocellular carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients [Phase 2]
Phase 2 trial assessing the combination of Envafolimab, Lenavatinib, and TACE in advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update investigating SHR-1210 combined with apatinib mesylate as perioperative therapy for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. [Phase 3]
Phase 3 trial comparing hepatic arterial infusion chemotherapy (HAIC) versus transarterial chemoembolization (TACE) for large hepatocellular…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: HAIC Plus Lenvatinib and Toripalimab for Advanced HCC [Phase 2]
Phase 2 clinical trial assessing hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and toripalimab for advanced hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial [Phase 2]
A single-arm Phase 2 trial evaluating HAIC plus A+T in high-risk hepatocellular carcinoma is being conducted, with unclear status.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]
Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria [Phase 2]
Phase 2 clinical trial evaluating TACE in combination with bevacizumab for hepatocellular carcinoma beyond the Up-To-Seven criteria (BCLC-B)…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC [Phase 3]
A Phase 3 trial compares lenvatinib plus sintilimab plus TACE versus lenvatinib plus TACE in non-resectable hepatocellular carcinoma under r…
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors [Phase 2]
A Phase 2 trial evaluating regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma who previously received PD-1/PD…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis [Phase 2]
A Phase 2 clinical trial evaluating H101 in combination with transarterial chemoembolization (TACE) for primary hepatocellular carcinoma wit…
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC [Phase 3]
Phase 3 trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with zoledronic acid to prevent bone metastases in advanced …
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. [Phase 3]
Phase 3 clinical trial evaluating anlotinib hydrochloride capsules with penpulimab for hepatocellular carcinoma at high risk of recurrence i…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma [Phase 2]
Phase 2 trial updating immunotherapy with nivolumab plus lenvatinib for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial in advanced hepatocellular carcinoma involving bavituximab, axitinib, and avelumab has been terminated; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC [Phase 2]
Phase 2 clinical trial evaluating regorafenib after progression on atezolizumab plus bevacizumab in advanced hepatocellular carcinoma is ong…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC [Phase 2]
A Phase 2 trial evaluating lenalidomide to reverse drug resistance after first-line treatment in advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating HAIC combined with cadonilimab and bevacizumab as first-line therapy for unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Ablation Combined With PD-1 in HCC: Phase II Study [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ablation combined with PD-1 blockade for hepatocellular carcinoma (HCC).
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial assessing cabozantinib in Japanese patients with advanced hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib with pembrolizumab as first-line therapy for advanced hepatocellular carcinoma was terminated; results…